Trial · NCT07555730
AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN)
NCT07555730, Phase 4, Not yet recruiting, Huazhong University of Science and Technology
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN). Trials, record NCT07555730. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07555730
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN)
- NCT number
- NCT07555730
- Status
- Not yet recruiting
- Phases
- Phase 4
- Enrollment
- 400 participants, estimated
- Lead sponsor
- Huazhong University of Science and Technology
- Conditions
- Overweight or Obesity; Type 2 Diabetes, Weight Loss Maintenance
- Interventions
- AI assisted multi-domain lifestyle intervention, Tirzepatide
- First posted
- 2026-04-29
- Last updated
- 2026-04-29
Source ClinicalTrials.gov
Registered outcomes32
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Body weight change (kg) | Change from randomization (week 20) to week 72 | Weight will be measured to the nearest 0.1 kg |
| Secondary | Percent change in body weight | Change from randomization (week 20) to week 72 | Percent change from week 20 to week 72 |
| Secondary | Body mass index | Change from randomization (week 20) to week 72 | Weight / Height\^2 (kg/m²) |
| Secondary | Waist and hip circumference | Change from randomization (week 20) to week 72 | Waist and hip circumference will be measured to the nearest 0.1cm |
| Secondary | Body fat percentage | Change from randomization (week 20) to week 72 | Change in body fat percentage (BF%) from randomization to the week 72 |
| Secondary | Skeletal muscle mass | Change from randomization (week 20) to week 72 | Change in skeletal muscle mass (SMM) from randomization to the week 72, measured in kg |
| Secondary | Fat mass | Change from randomization (week 20) to week 72 | Change in fat mass (FM) from randomization to the week 72, measured in kg |
| Secondary | Fat free mass | Change from randomization (week 20) to week 72 | Change in fat free mass (FFM) from randomization to the week 72, measured in kg |
| Secondary | Blood pressure | Change from randomization (week 20) to week 72 | Blood pressure (systolic/diastolic) will be measured with a digital blood pressure monitor in sitting position (mmHg) |
| Secondary | Concentration of glycated hemoglobin (HbA1c) | Change from randomization (week 20) to week 72 | Concentration of HbA1c, measured in the percentage of hemoglobin |
1 to 10 of 32Source ClinicalTrials.gov
See all 32 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07555730
GET https://conductscience.org/api/trials/v1/NCT07555730/registered?page=2